FDMT vs HAS · rev $37.0K vs P/E 25, rev $4.75B
4D Molecular Therapeutics Inc (FDMT) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
FDMT currently screens at market cap $518.1M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the FDMT and HAS stock pages for the full models.
Not investment advice.